From: Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome
Independent variable | β | S.E. | p | OR | 95% CI |
---|---|---|---|---|---|
Serum LCN2@ | 0.797 | 0.398 | 0.045 | 2.218 | 1.017-4.839 |
Anti-hypertensive therapy | -1.022 | 0.489 | 0.036 | 0.360 | 0.138-0.938 |
Lipid-lowering therapy | 1.232 | 0.539 | 0.022 | 3.428 | 1.192-9.864 |